Skip to content

DNA on Demand: What Pharmacists Need to Know about Direct-to-Consumer Pharmacogenomic Testing

Live Webinar
March 25, 2021 | 4:00 pm – 5:00 pm EST

This activity is designed for healthcare professionals seeking information on available direct-to-consumer genetic testing kits, and how to approach counseling patients when presented with the results from a kit.

Registration is required if you would like to earn ACPE credit for attending.

Learning Objectives

Upon completion of this activity, the participant will be able to:

  • Identify the benefits and limitations of direct-to-consumer (DTC) pharmacogenomic testing.
  • Describe freely-available, evidence-based resources for evaluating the clinical implications of DTC pharmacogenomic test results.
  • Review key considerations for counseling patients about DTC pharmacogenomic testing.


Roseann S. Gammal, PharmD, BCPS:
Roseann S. Gammal, PharmD, BCPS is an Assistant Professor of Pharmacy Practice at MCPHS University in Boston, MA. She received her Bachelor of Science degrees in Chemistry and Biochemistry from Worcester Polytechnic Institute and her Doctor of Pharmacy degree from MCPHS University in Worcester, MA. She completed a PGY1 Pharmacy Practice residency at the University of North Carolina Medical Center in Chapel Hill, NC and a PGY2 specialty residency in Clinical Pharmacogenetics at St. Jude Children’s Research Hospital in Memphis, TN. Dr. Gammal is a Board Certified Pharmacotherapy Specialist and a nationally recognized expert in the field of pharmacogenomics. She has recently served as Chair of both the American College of Clinical Pharmacy’s Pharmacokinetics/Pharmacodynamics/Pharmacogenomics Practice and Research Network and the American Association of Colleges of Pharmacy’s Pharmacogenomics Special Interest Group. In addition, she works with the NIH-funded Clinical Pharmacogenetics Implementation Consortium to create evidence-based clinical practice guidelines that describe how to use pharmacogenomic test results to optimize medication therapy. Dr. Gammal is also the co-founder and lead clinical pharmacist for the Pharmacogenomics Clinic at Brigham and Women’s Hospital in Boston.

There is no fee to attend this event.


ACPE logo

Universal Activity Number: 0026-0000-21-124-L04-P | Knowledge-based


MCPHS University is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. MCPHS designates this educational activity for a total of 1 contact hours (0.1 CEUs).

Requirements for Credit

Partial credit will not be awarded. To claim credit participants must log into their profile on MCPHS CE portal and insert the specific activity code for this webinar in order to access and complete the evaluation. CE credit will be automatically uploaded to CPE Monitor upon completion of the evaluation and posted to the participant’s NABP account within 72 hours.

Attendance will be verified. Credit will not be issued to participants who join the meeting more than 15 minutes after the start of the meeting or to those who depart early. Credit cannot be awarded to individuals who complete the activity evaluation more than 60 days post activity.


All participants will have the opportunity to review the educational session and speakers, and to identify future educational needs.

Statement of Disclosure

MCPHS University adheres to the ACPE Standards for Integrity and Independence in Continuing Education. It is the policy of MCPHS University that the speakers and planning committee members disclose all financial relationships with ineligible companies, and that relevant conflicts of interest are resolved. Speakers will disclose any unlabeled/unapproved use of drugs or devices during their presentation.

No funding from industry provided for this event. No exhibitors will be present.
Roseann Gammal has no relevant financial relationships with ineligible companies to disclose.
All CE staff members have no relevant financial relationships with ineligible companies to disclose.

Reed Conference Logo